Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial - The Lancet
Clinical Outcomes of Selective Versus Nonselective His Bundle Pacing - ScienceDirect
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
TCT-567 Long-Term Outcomes With an Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent Versus a Cobalt-Chromium Everolimus-Eluting Stent in Single De Novo Coronary Lesions: Four-Year Results of the TARGET I Randomized Controlled Trial
TCT-64 Two-Year Clinical and Imaging Outcomes of Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffolds in De Novo Coronary Artery Lesions: The MeRes-1 Trial
PDF) De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ dnDSA following heart transplantation
Frontiers The long-term clinical outcomes of intravascular ultrasound-guided versus angiography-guided coronary drug eluting stent implantation in long de novo coronary lesions: A systematic review and meta-analysis
PDF) Clinical Characteristics of De Novo Heart Failure and Acute Decompensated Chronic Heart Failure: Are They Distinctive Phenotypes That Contribute to Different Outcomes?
Clinical Presentation and In-Hospital Trajectory of Heart Failure and Cardiogenic Shock - ScienceDirect
Effects of Upgrade Versus De Novo Cardiac Resynchronization Therapy on Clinical Response and Long-Term Survival
Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block - ScienceDirect
PDF) “De Novo” Heart Failure: A Mechanism Underscoring Sex Differences in Outcomes After ST-Segment Elevation Myocardial Infarction